Dashboard
Manage Tickers

ADPT


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jp-morgan-maintains-overweight-on-adaptive-biotechnologies-raises-price-target-to-20
JP Morgan Maintains Overweight on Adaptive...
11/06/2025 21:15:43

JP Morgan analyst Rachel Vatnsdal maintains Adaptive Biotechnologies (NASDAQ:ADPT) with a Overweight and raises the price ta...

correction-adaptive-biotechnologies-q3-adj-eps-015-inline-sales-60200m-miss-64643m-estimate
CORRECTION: Adaptive Biotechnologies Q3 Ad...
11/06/2025 00:40:45

Adaptive Biotechnologies (NASDAQ:ADPT) reported quarterly losses of $(0.15) per share which met the analyst consensus estimate....

earnings-scheduled-for-november-5-2025
Earnings Scheduled For November 5, 2025
11/05/2025 11:12:12

cathie-wood-goes-all-in-on-peter-thiels-crypto-play-bullish-with-back-to-back-million-dollar-buys
Cathie Wood Goes All-In On Peter Thiel's C...
11/05/2025 01:42:01

Cathie Wood-led Ark Invest purchased shares in Bullish, a crypto exchange backed by Peter Thiel, through three of its funds. Ot...

btig-maintains-buy-on-adaptive-biotechnologies-raises-price-target-to-19
BTIG Maintains Buy on Adaptive Biotechnolo...
10/22/2025 12:02:19

BTIG analyst Mark Massaro maintains Adaptive Biotechnologies (NASDAQ:ADPT) with a Buy and raises the price target from $14 t...

piper-sandler-maintains-overweight-on-adaptive-biotechnologies-raises-price-target-to-20
Piper Sandler Maintains Overweight on Adap...
10/15/2025 13:56:41

Piper Sandler analyst David Westenberg maintains Adaptive Biotechnologies (NASDAQ:ADPT) with a Overweight and raises the pri...

tesla-to-300-here-are-10-top-analyst-forecasts-for-monday
Tesla To $300? Here Are 10 Top Analyst For...
10/13/2025 13:43:21

jp-morgan-maintains-overweight-on-adaptive-biotechnologies-raises-price-target-to-17
JP Morgan Maintains Overweight on Adaptive...
10/13/2025 13:19:44

JP Morgan analyst Sebastian Sandler maintains Adaptive Biotechnologies (NASDAQ:ADPT) with a Overweight and raises the price ...

a-glimpse-into-the-expert-outlook-on-adaptive-biotechnologies-through-4-analysts
A Glimpse Into The Expert Outlook On Adapt...
09/30/2025 20:00:47

united-natural-foods-posts-upbeat-results-joins-anaptysbio-semtech-uipath-and-other-big-stocks-moving-higher-on-tuesday
United Natural Foods Posts Upbeat Results,...
09/30/2025 15:06:57

guggenheim-initiates-coverage-on-adaptive-biotechnologies-with-buy-rating-announces-price-target-of-20
Guggenheim Initiates Coverage On Adaptive ...
09/30/2025 14:16:31

Guggenheim analyst Subbu Nambi initiates coverage on Adaptive Biotechnologies (NASDAQ:ADPT) with a Buy rating and announces ...

jp-morgan-maintains-overweight-on-adaptive-biotechnologies-raises-price-target-to-14
JP Morgan Maintains Overweight on Adaptive...
08/06/2025 22:42:44

JP Morgan analyst Rachel Vatnsdal maintains Adaptive Biotechnologies (NASDAQ:ADPT) with a Overweight and raises the price ta...

td-cowen-maintains-buy-on-adaptive-biotechnologies-raises-price-target-to-15
TD Cowen Maintains Buy on Adaptive Biotech...
08/06/2025 18:32:06

TD Cowen analyst Dan Brennan maintains Adaptive Biotechnologies (NASDAQ:ADPT) with a Buy and raises the price target from $1...

piper-sandler-maintains-overweight-on-adaptive-biotechnologies-raises-price-target-to-15
Piper Sandler Maintains Overweight on Adap...
08/06/2025 15:54:39

Piper Sandler analyst David Westenberg maintains Adaptive Biotechnologies (NASDAQ:ADPT) with a Overweight and raises the pri...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/05/2025 21:07:20

adaptive-biotechnologies-q2-eps-017-beats-024-estimate-sales-58879m-beat-49400m-estimate
Adaptive Biotechnologies Q2 EPS $(0.17) Be...
08/05/2025 20:06:28

Adaptive Biotechnologies (NASDAQ:ADPT) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate...

Core News & Articles
Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

cathie-woods-ark-invest-loads-up-on-absci-offloads-crispr-therapeutics
Cathie Wood's Ark Invest Loads Up On Absci...
07/26/2025 05:25:42

Ark Invest traded in VCYT, IRDM, CRSP, KTOS, ABSI, VEEV, ADPT, and GH. Mainly focused on healthcare innovation.

adaptive-biotechnologies-integrates-adaptives-clonosseq-test-for-mrd-assessment-in-lymphoid-malignancies-into-oncoemr-flatirons-cloud-based-emr-platform
Adaptive Biotechnologies Integrates Adapti...
07/01/2025 11:31:52

Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetic...

cathie-woods-ark-invest-adds-airbnb-amd-shopify-to-portfolio-slashes-stake-in-circle-internet
Cathie Wood's Ark Invest Adds Airbnb, AMD,...
06/21/2025 04:19:01

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION